NCT04399031

Brief Summary

This project will assess the ways in which e-cigarette product diversity impacts the user experience to inform potential regulations by identifying product characteristics that may: (1) put young adults at risk for tobacco product use; and (2) facilitate adult smokers switching to e-cigarettes. There are three primary objectives to the study: (1) Determine which dimensions of e-cigarette product diversity differentially affect product appeal in the overall population of tobacco product users as well as affect product appeal across young adult e-cigarette users and middle-age/older adult smokers; (2) Determine which dimensions of e-cigarette product diversity differentially affect product appeal in the overall population of tobacco product users as well as affect abuse liability in young adult e-cigarette users and the ability to resist smoking in adult smokers; (3) Determine the affect of product characteristics on e-cigarette nicotine delivery profile. For this substudy, young adult vapers (N=100) and adult smokers (N=100) will attend one laboratory session in which they will self-administer e-cigarette products varied according to within-subject e-cigarette factors (e.g., flavor, nicotine formulation).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
124

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2019

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2020

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

May 18, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 22, 2020

Completed
Last Updated

July 11, 2023

Status Verified

July 1, 2023

Enrollment Period

3 months

First QC Date

May 18, 2020

Last Update Submit

July 7, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Subjective Appeal

    Self-report measures of product appeal will be completed following e-cigarette self-administration.

    1 hour

  • Sensory Appeal

    Self-report measures of product appeal will be completed following e-cigarette self-administration.

    1 hour

Study Arms (20)

E-cigarette e-liquid 1

EXPERIMENTAL

Participants will self-administer an e-cigarette e-liquid.

Drug: E-cigarette e-liquid

E-cigarette e-liquid 2

EXPERIMENTAL

Participants will self-administer an e-cigarette e-liquid.

Drug: E-cigarette e-liquid

E-cigarette e-liquid 3

EXPERIMENTAL

Participants will self-administer an e-cigarette e-liquid.

Drug: E-cigarette e-liquid

E-cigarette e-liquid 4

EXPERIMENTAL

Participants will self-administer an e-cigarette e-liquid.

Drug: E-cigarette e-liquid

E-cigarette e-liquid 5

EXPERIMENTAL

Participants will self-administer an e-cigarette e-liquid.

Drug: E-cigarette e-liquid

E-cigarette e-liquid 6

EXPERIMENTAL

Participants will self-administer an e-cigarette e-liquid.

Drug: E-cigarette e-liquid

E-cigarette e-liquid 7

EXPERIMENTAL

Participants will self-administer an e-cigarette e-liquid.

Drug: E-cigarette e-liquid

E-cigarette e-liquid 8

EXPERIMENTAL

Participants will self-administer an e-cigarette e-liquid.

Drug: E-cigarette e-liquid

E-cigarette e-liquid 9

EXPERIMENTAL

Participants will self-administer an e-cigarette e-liquid.

Drug: E-cigarette e-liquid

E-cigarette e-liquid 10

EXPERIMENTAL

Participants will self-administer an e-cigarette e-liquid.

Drug: E-cigarette e-liquid

E-cigarette e-liquid 11

EXPERIMENTAL

Participants will self-administer an e-cigarette e-liquid.

Drug: E-cigarette e-liquid

E-cigarette e-liquid 12

EXPERIMENTAL

Participants will self-administer an e-cigarette e-liquid.

Drug: E-cigarette e-liquid

E-cigarette e-liquid 13

EXPERIMENTAL

Participants will self-administer an e-cigarette e-liquid.

Drug: E-cigarette e-liquid

E-cigarette e-liquid 14

EXPERIMENTAL

Participants will self-administer an e-cigarette e-liquid.

Drug: E-cigarette e-liquid

E-cigarette e-liquid 15

EXPERIMENTAL

Participants will self-administer an e-cigarette e-liquid.

Drug: E-cigarette e-liquid

E-cigarette e-liquid 16

EXPERIMENTAL

Participants will self-administer an e-cigarette e-liquid.

Drug: E-cigarette e-liquid

E-cigarette e-liquid 17

EXPERIMENTAL

Participants will self-administer an e-cigarette e-liquid.

Drug: E-cigarette e-liquid

E-cigarette e-liquid 18

EXPERIMENTAL

Participants will self-administer an e-cigarette e-liquid.

Drug: E-cigarette e-liquid

E-cigarette e-liquid 19

EXPERIMENTAL

Participants will self-administer an e-cigarette e-liquid.

Drug: E-cigarette e-liquid

E-cigarette e-liquid 20

EXPERIMENTAL

Participants will self-administer an e-cigarette e-liquid.

Drug: E-cigarette e-liquid

Interventions

Participants will self-administer an experimenter-provided e-cigarette.

E-cigarette e-liquid 1E-cigarette e-liquid 10E-cigarette e-liquid 11E-cigarette e-liquid 12E-cigarette e-liquid 13E-cigarette e-liquid 14E-cigarette e-liquid 15E-cigarette e-liquid 16E-cigarette e-liquid 17E-cigarette e-liquid 18E-cigarette e-liquid 19E-cigarette e-liquid 2E-cigarette e-liquid 20E-cigarette e-liquid 3E-cigarette e-liquid 4E-cigarette e-liquid 5E-cigarette e-liquid 6E-cigarette e-liquid 7E-cigarette e-liquid 8E-cigarette e-liquid 9

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Vapers/E-cigarette Users
  • E-cigarette/vaping device use at least three days per week for at least 2 months
  • Regular use of e-cigarettes/vaping devices containing nicotine
  • Cigarette Smokers
  • Daily cigarette smoking for at least two years
  • Currently smoke at least four cigarettes per day
  • Interested in trying an e-cigarette or current use of an e-cigarette

You may not qualify if:

  • Vapers/E-cigarette Users
  • Pregnant or breastfeeding
  • Desire to cut down on use of e-cigarette/vaping device
  • Cigarette Smokers
  • Pregnant or breastfeeding
  • Current daily use of other combustible tobacco products (such as cigars)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Southern California

Los Angeles, California, 90033, United States

Location

Related Publications (2)

  • Tackett AP, Dai HD, Han DH, Vogel EA, Coreas SI, Jafarzadeh N, Gonzalez Anaya MJ, Patel D, Peraza N, Mason TB, Leventhal AM. Appeal of e-cigarette flavors: Differences between never and ever use of combustible cigarettes. Drug Alcohol Depend. 2023 May 1;246:109849. doi: 10.1016/j.drugalcdep.2023.109849. Epub 2023 Mar 23.

  • Leventhal AM, Madden DR, Peraza N, Schiff SJ, Lebovitz L, Whitted L, Barrington-Trimis J, Mason TB, Anderson MK, Tackett AP. Effect of Exposure to e-Cigarettes With Salt vs Free-Base Nicotine on the Appeal and Sensory Experience of Vaping: A Randomized Clinical Trial. JAMA Netw Open. 2021 Jan 4;4(1):e2032757. doi: 10.1001/jamanetworkopen.2020.32757.

MeSH Terms

Conditions

VapingCigarette Smoking

Condition Hierarchy (Ancestors)

SmokingBehaviorTobacco SmokingTobacco Use

Study Officials

  • Adam M Leventhal, PhD

    University of Southern California

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Preventive Medicine

Study Record Dates

First Submitted

May 18, 2020

First Posted

May 22, 2020

Study Start

December 1, 2019

Primary Completion

March 1, 2020

Study Completion

March 1, 2020

Last Updated

July 11, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share

Locations